In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Techniclone and Merck sign tumour necrosis therapy agreement
Techniclone issued patent extending vascular targeting agent portfolio
Mitotix announces three U.S. Patents on p16 tumour suppressor gene
Cell Genesys issued additional patent for AAV gene therapy technology
Techniclone exercises option for anti-angiogenesis antibody
TRANSGENE issued patent for adenoviral gene therapy technology
Techniclone and Scotia complete license agreement